University of North Dakota
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of North Dakota sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).
University of North Dakota: 4 sponsored US clinical trials, 1 recruiting.
University of North Dakota sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Lung Cancer, with 2 trials.
Upper-quartile sponsor footprint
University of North Dakota sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Promoting Radon Testing Among Mothers of Young Children
NCT07591389
Health Effects of Traditional Indigenous Chokeberry
NCT05410327
Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures
NCT05319457
Promoting Radon Testing Via Smartphone App: A Clinical Trial in a High Radon State
NCT04980521
Therapeutic Areas
What is open in the University of North Dakota pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Lung Cancer (2 trials), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.